Spot gold just broke through the $2,710.00/oz mark, and the latest price was $2,709.91/oz, down 0.29% in the day; COMEX gold futures main force recently reported $2,744.30 per ounce, down 0.45% in the day.Li Ziyuan: The plan to reduce the holdings of directors, supervisors and senior managers has not been completed. Li Ziyuan announced the change. On October 1, 2024, the company disclosed the Announcement on the Plan to Reduce the Holdings of Some Directors, Supervisors and Senior Managers of Zhejiang Li Ziyuan Food Co., Ltd. Zhu Wenxiu and other six directors, supervisors and senior managers plan to reduce their holdings by centralized bidding, which does not exceed 1,190,607 shares, and does not exceed 1% of the company's total share capital. As of December 12, 2024, the above-mentioned directors, supervisors and senior managers reduced their holdings of 813,400 shares through centralized bidding. At present, the share reduction plan has not been completed.South Korea's Seoul Composite Index rose to 1%.
The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.Morgan Stanley lowered Macy's target price from $17.00 to $16.00.CEO of STELLANTIS Europe: We will never pay a fine for the EU emission reduction requirements in 2025, and we are ready to reduce production to avoid this situation.
Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.Tongfu Microelectronics traded 2.24 million shares at a discount of 60.0768 million yuan today. Tongfu Microelectronics traded 2.24 million shares at a discount of 60.0768 million yuan today, accounting for 3.32% of the total turnover of the day, and the transaction price was 26.82 yuan, which was 9.97% lower than the market closing price of 29.79 yuan.Xia Yiping, CEO of Extreme Vietnam: I am only a minority shareholder of the company, and Baidu has 80% of the voting rights. I learned from employees inside Extreme Vietnam that Xia Yiping, CEO of Extreme Vietnam, communicated with employee representatives about the company this afternoon. He revealed that the board of directors had a meeting the night before the 11th solution was released, and no agreement was reached on employee social security. It is not up to you to decide the plan that is released only after you get the resolution from the board of directors. "I said that I could take some money to solve the social security problem of employees, but in this case, neither shareholder stood up." He said that he is the CEO of the company, but he is only a minority shareholder and has decision-making power in business, but he has no decision-making power in the development of the company and needs the decision of the board of directors. 80% of the voting rights of the company are in Baidu. Baidu has just conducted a comprehensive audit of the company recently, and there are no problems. (Sina Technology)
Strategy guide 12-14
Strategy guide
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14